Loading clinical trials...
Loading clinical trials...
Swiss Primary Hypersomnolence and Narcolepsy Cohort Study (SPHYNCS) is a cohort study on disease presentation and long-term course with an exploratory approach to detect biomarkers.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Insel Gruppe AG, University Hospital Bern
Collaborators
NCT07299097 · Narcolepsy Type 1, Narcolepsy Type 2
NCT07363720 · Narcolepsy Type 1 (NT1), Narcolepsy With Cataplexy
NCT05816382 · Narcolepsy Type 1
NCT06767683 · Narcolepsy Type 1, Narcolepsy Type 2, and more
NCT06952699 · Narcolepsy Type 2
Claudio L Bassetti
Bern
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions